Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
(World News USA)

BOSTON, April 2, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has acquired enicor GmbH, a privately held manufacturer of a new generation whole blood coagulation testing system (ClotPro®), which is based in Munich, Germany. The ClotPro system is an innovative viscoelastic diagnostic device that offers more assays than any other hemostasis analyzer on the market. Under the terms of the transaction, Haemonetics has acquired all of the outstanding share capital of enicor GmbH. `The enicor team and technology are a natural fit for...